Company / Free Cash Flow per Share
Cartesian Therapeutics, Inc. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.27
FY2025
5-year range
-$9.52 / $0.28
FY2021-FY2025
Trend
+86.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share returned to growth in FY2025 after 2 years of decline, reaching $-1.27.
Based on SEC 10-K filings.
-1.27 in FY2025.
Declined from $-0.40 to $-1.27 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow per share increased 86.6% year-over-year.
- Peak free cash flow per share was recorded in FY2022.
- Lowest free cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.27 | +86.6% |
| FY2024 | -$9.52 | -2269.5% |
| FY2023 | -$0.40 | -245.7% |
| FY2022 | $0.28 | +157.8% |
| FY2021 | -$0.48 | +31.5% |
| FY2020 | -$0.70 | +70.4% |
| FY2019 | -$2.35 | +60.5% |
| FY2016 | -$5.94 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026